Rating History for Kalvista Pharmaceuticals Inc (KALV) by Stifel
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/7/2026 | Paul Matteis | Downgrade | Hold (Buy) |
27.00 (42.00) |
42.00 (27.00) |
-35.71% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/7/2026 | Paul Matteis | Downgrade | Hold (Buy) |
27.00 (42.00) |
42.00 (27.00) |
-35.71% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||